Skip to content
NeuroTechGuide

US Treasury proposes barring new US investment in Chinese brain-computer interface companies

A proposed rule under the COINS Act adds biotechnology to US outbound investment controls and would prohibit most new US investment in BCI developers tied to China and other countries of concern.

1 min readPolicy & ethicsRegulationIndustry

On October 22, the US Department of the Treasury published a proposed rule that adds biotechnology to its outbound investment controls and would prohibit US investment involving brain-computer interfaces in companies linked to “countries of concern.” These are China (including Hong Kong and Macau), Cuba, Iran, North Korea and Russia. It is a proposal, not a final rule. Public comments are due December 7, 2026.

Background

The rule implements the Comprehensive Outbound Investment National Security (COINS) Act. Congress passed it as part of the fiscal year 2026 National Defense Authorization Act. The law names five technology areas: semiconductors, artificial intelligence, quantum information, high-performance computing and hypersonics. It also lets the Treasury Secretary add more. Treasury used that power to add biotechnology, and BCIs fall in the prohibited tier.

The program has two tiers. Some deals must be reported to Treasury, while others are banned outright. According to Inside BCI’s reading of the proposal, the BCI category covers invasive, partially invasive and non-invasive systems and their software. Covered deals include equity stakes, convertible loans, joint ventures and some fund commitments. The proposal excepts ordinary purchases of publicly traded shares, and it would not apply to deals completed before the final rule takes effect.

Why it matters

  • China has some of the world’s best-funded BCI companies, several preparing stock listings. Treasury names no companies, but the rule could cut off a source of US venture money for the sector.
  • It is the first time BCIs have been singled out in US investment controls. This adds to a growing US debate about BCI competition with China.
  • Details could change after the comment period, and Treasury has not estimated how many deals would be affected. Inside BCI reports that China’s foreign ministry criticized the move on October 23.

Learn more: Brain-computer interface · Dual use · Chinese BCI companies line up for IPOs

Share:XLinkedInBlueskyEmail

More news